SIMPLIFYING TURN-IN Tactical vehicles sit on the flight line before being transported to support retrograde operations in March 2015 at Kandahar Airfield, Afghanistan. ALLP data indicate that incorporating the appropriate personnel in retrograde and turn-in operations enables the process to operate much more smoothly. (U.S. Air Force photo by SSgt Whitney Amstutz, 27th Special Operations Wing Public Affairs)


Given the timeline to meet this requirement, the program did not benefit from an independent cost-benefit analysis to substan- tiate the competitive prototyping waiver (already being executed to support Milestone B). Further, the defense acquisition execu- tive (DAE) required the final competitive prototyping waiver at the Milestone A Defense Acquisition Board (DAB). Te result was an extraordinary effort to staff and develop the competitive prototyping waiver package.


Developing the program’s competitive prototype waiver before the acquisition decision memorandum was signed by the DAE required a detailed cost-benefit analysis to verify the costs for government and industry throughout the entire life cycle of the program, not just during prototype development and fabrica- tion. Since the product office was unaware of this requirement at the start of MSA, a cost-benefit analysis was not completed before Milestone A. Program officials planned to complete the cost-benefit analysis as part of the TMRR activities in sup- port of preparations for the Milestone B decision leading into the engineering and manufacturing development phase of the


program. As a result, the program office was not able to use an independent agency to develop a comprehensive cost- benefit analysis. Extraordinary effort and management focus were required because of the limited time allowed for completing the waiver and having it reviewed by Army and Office of the Secretary of Defense (OSD) staffs so that it was ready for DAE signature at the Milestone A DAB.


Recommendation Ensure that a cost-benefit analysis considers all technology development costs during TMRR, including prototype develop- ment, as well as all costs across the life cycle of the program, and is completed by an independent agency within sufficient time to inform a competitive prototyping waiver before Milestone A.


BETTER BUYING POWER


LL_289: Programs that need to transition into programs of record (PORs) and do not have research, development, test and evaluation (RDT&E) funds may be able to acquire


ASC.ARMY.MIL 39


ACQUISITION


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208